SRC-related_JJ
proto-oncogenes_NNS
and_CC
transcription_NN
factors_NNS
in_IN
primary_JJ
human_JJ
T_NN
cells_NNS
:_:
modulation_NN
by_IN
cyclosporin_NN
A_NN
and_CC
FK506_NN
._.

Activation_NN
of_IN
T_NN
lymphocytes_NNS
induces_VBZ
transcription_NN
of_IN
genes_NNS
encoding_VBG
for_IN
lymphokines_NNS
._.

Interleukin-2_NN
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
gene_NN
expression_NN
is_VBZ
controlled_VBN
transcriptionally_RB
by_IN
the_DT
cooperative_JJ
activity_NN
of_IN
specific_JJ
trans-activating_JJ
factors_NNS
that_WDT
bind_VBP
to_TO
the_DT
IL-2_NN
enhancer_NN
._.

Cyclosporin_NN
A_NN
-LRB-_-LRB-
CsA_NN
-RRB-_-RRB-
and_CC
FK506_NN
inhibit_VBP
the_DT
production_NN
of_IN
IL-2_NN
in_IN
T_NN
lymphocytes_NNS
at_IN
the_DT
level_NN
of_IN
gene_NN
transcription_NN
._.

A_DT
member_NN
of_IN
the_DT
src_NN
gene_NN
family_NN
,_,
the_DT
lymphocyte-specific_JJ
protein_NN
tyrosine_NN
kinase_NN
,_,
p56lck_NN
,_,
has_VBZ
been_VBN
implicated_VBN
in_IN
IL-2_NN
production_NN
._.

CsA_NN
was_VBD
found_VBN
not_RB
to_TO
inhibit_VB
lck_NN
gene_NN
expression_NN
,_,
nor_CC
the_DT
activity_NN
of_IN
the_DT
lck_NN
gene_NN
product_NN
._.

However_RB
,_,
CsA_NN
and_CC
FK506_NN
inhibit_VBP
the_DT
appearance_NN
of_IN
DNA_NN
binding_NN
activity_NN
of_IN
factors_NNS
that_WDT
bind_VBP
to_TO
the_DT
NF-AT_NN
and_CC
AP-1_NN
sites_NNS
in_IN
the_DT
IL-2_NN
enhancer_NN
._.

Since_IN
the_DT
induction_NN
of_IN
NF-AT_NN
and_CC
AP-1_NN
is_VBZ
induced_VBN
by_IN
the_DT
same_JJ
stimuli_NNS
that_WDT
stimulate_VB
IL-2_NN
production_NN
,_,
these_DT
results_NNS
indicate_VBP
that_IN
the_DT
immunosuppressant_JJ
action_NN
of_IN
CsA_NN
and_CC
FK506_NN
is_VBZ
exerted_VBN
at_IN
the_DT
level_NN
of_IN
these_DT
trans-activating_JJ
factors_NNS
._.

